ECSP099631A - Composiciones de chitosanes para el tratamiento de enfermedades inflamatorias de las uñas - Google Patents

Composiciones de chitosanes para el tratamiento de enfermedades inflamatorias de las uñas

Info

Publication number
ECSP099631A
ECSP099631A EC2009009631A ECSP099631A ECSP099631A EC SP099631 A ECSP099631 A EC SP099631A EC 2009009631 A EC2009009631 A EC 2009009631A EC SP099631 A ECSP099631 A EC SP099631A EC SP099631 A ECSP099631 A EC SP099631A
Authority
EC
Ecuador
Prior art keywords
chitosan
nails
inflammatory diseases
chitosanes
compositions
Prior art date
Application number
EC2009009631A
Other languages
English (en)
Spanish (es)
Inventor
Federico Mailland
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38212471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP099631(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of ECSP099631A publication Critical patent/ECSP099631A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
EC2009009631A 2007-02-14 2009-09-14 Composiciones de chitosanes para el tratamiento de enfermedades inflamatorias de las uñas ECSP099631A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07102338A EP1958639A1 (en) 2007-02-14 2007-02-14 Use of chitosans for the treatment of nail inflammatory diseases

Publications (1)

Publication Number Publication Date
ECSP099631A true ECSP099631A (es) 2009-12-28

Family

ID=38212471

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009631A ECSP099631A (es) 2007-02-14 2009-09-14 Composiciones de chitosanes para el tratamiento de enfermedades inflamatorias de las uñas

Country Status (30)

Country Link
US (1) US8906881B2 (enExample)
EP (3) EP1958639A1 (enExample)
JP (3) JP2010518139A (enExample)
KR (1) KR101468479B1 (enExample)
CN (1) CN101641103B (enExample)
AR (1) AR065317A1 (enExample)
AU (1) AU2008214695B2 (enExample)
BR (1) BRPI0807596A2 (enExample)
CA (1) CA2676259C (enExample)
CL (1) CL2008000443A1 (enExample)
CO (1) CO6210818A2 (enExample)
CY (1) CY1113822T1 (enExample)
DK (1) DK2117565T3 (enExample)
EA (1) EA019539B1 (enExample)
EC (1) ECSP099631A (enExample)
ES (1) ES2394169T3 (enExample)
HR (1) HRP20120915T1 (enExample)
IL (1) IL200091A (enExample)
MA (1) MA31237B1 (enExample)
ME (1) ME00828B (enExample)
MX (1) MX2009008514A (enExample)
MY (1) MY150502A (enExample)
NZ (1) NZ578937A (enExample)
PL (1) PL2117565T3 (enExample)
PT (1) PT2117565E (enExample)
RS (1) RS52620B (enExample)
SI (1) SI2117565T1 (enExample)
UA (1) UA101151C2 (enExample)
WO (1) WO2008098871A2 (enExample)
ZA (1) ZA200904975B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
CA2622204C (en) 2005-09-12 2016-10-11 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
US9427419B2 (en) 2005-09-12 2016-08-30 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (DMSO)
US10201490B2 (en) * 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
CA2749141A1 (en) * 2009-01-08 2010-07-15 Allergan, Inc. Cyclosporine compositions for enhancing nail growth
AU2010313253B2 (en) 2009-10-30 2015-02-19 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EA033767B1 (ru) * 2014-06-10 2019-11-22 Makhbuba Nabi Kyzy Velieva Средство против выпадения волос на основе лекарственных растений
PL233616B1 (pl) 2017-08-10 2019-11-29 Podopharm Spolka Z Ograniczona Odpowiedzialnoscia Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu
KR102511613B1 (ko) * 2019-09-23 2023-03-17 포항공과대학교 산학협력단 키토산을 포함하는 면역억제용 조성물 및 이의 용도

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE378109B (enExample) 1972-05-19 1975-08-18 Bofors Ab
DE3541305A1 (de) 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
JPH08245401A (ja) * 1995-03-14 1996-09-24 Osamu Hatanaka 皮膚保護剤
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US7147854B2 (en) * 1997-06-23 2006-12-12 Yes Biotech Laboratories Ltd. Topical treatment of psoriasis using neutralizing antibodies to interleukin-8
JP4185173B2 (ja) 1997-08-07 2008-11-26 株式会社ノエビア 両親媒性キトサン誘導体及びこれを含有する皮膚外用剤
DE59911740D1 (de) * 1998-09-10 2005-04-14 Bioequal Ag Muttenz Topisch anwendbare mittel gegen nagelpilzerkrankungen
DE19911056B9 (de) 1999-03-12 2005-09-08 Biotec Asa Kosmetische Zubereitungen und deren Verwendung
JP2001055335A (ja) * 1999-08-18 2001-02-27 Toshio Sato アレルギー性皮膚疾患治療剤
JP2001131030A (ja) * 1999-11-08 2001-05-15 Kureha Chem Ind Co Ltd 発毛促進剤
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
NO20005718A (no) 2000-11-13 2001-06-05 Ethics Cosmeceuticals Ab Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugert vitamin A samt fremgangsmåte for fremstilling og anvendelse av denne
KR20020048534A (ko) 2000-12-18 2002-06-24 안병로 파라핀 왁스를 유효성분으로 하는 피부 맛사지 팩제
SE0100166D0 (sv) 2001-01-22 2001-01-22 Tacton Systems Ab Configuration system
KR100457546B1 (ko) 2001-05-02 2004-11-18 주식회사 바이오프로젠 폴리프럭토오스 또는 그 유도체를 이용한 미소구 및 그제조방법
GB0126923D0 (en) 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
EP1455802B1 (en) * 2001-12-14 2008-10-15 Dnp Canada Inc. Uses of chitosan oligosaccharides
KR100470753B1 (ko) * 2003-01-09 2005-03-10 주식회사 자광 수용성 천연필름과 그의 제조방법
JP2004231604A (ja) 2003-01-31 2004-08-19 Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai 担体シートおよび徐放性製剤ならびにそれらの製法
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
US20050112151A1 (en) 2003-11-20 2005-05-26 Horng Liou L. Skin adherent hydrogels
RU2258516C1 (ru) * 2004-01-20 2005-08-20 Государственное Образовательное Учреждение "Красноярская Государственная Медицинская Академия Министерства Здравоохранения Российской Федерации" Способ лечения красного плоского лишая
JP2005306746A (ja) 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
JP4804770B2 (ja) * 2005-02-28 2011-11-02 株式会社アリミノ ヘアーコンディショニング剤およびその使用方法
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
JP5632125B2 (ja) 2005-06-14 2014-11-26 ジェニス イーエイチエフ．Ｇｅｎｉｓ ｅｈｆ． 部分的脱アセチル化キチン誘導体の組成物
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
EP1842545A1 (en) * 2006-04-04 2007-10-10 Marinomed Biotechnologie GmbH Anti-inflammatory polymer
DE102006049585A1 (de) * 2006-10-22 2008-04-24 Susilo, Rudy, Dr. Nagellack für kosmetische und medizinische Anwendungen

Also Published As

Publication number Publication date
NZ578937A (en) 2012-05-25
AU2008214695A1 (en) 2008-08-21
IL200091A0 (en) 2010-04-15
BRPI0807596A2 (pt) 2014-07-22
KR20090121302A (ko) 2009-11-25
MX2009008514A (es) 2009-08-20
EP1958639A1 (en) 2008-08-20
US20100104670A1 (en) 2010-04-29
US8906881B2 (en) 2014-12-09
RS52620B (sr) 2013-06-28
JP6035292B2 (ja) 2016-11-30
KR101468479B1 (ko) 2014-12-05
CA2676259C (en) 2015-07-14
EA200901113A1 (ru) 2010-02-26
JP2010518139A (ja) 2010-05-27
MY150502A (en) 2014-01-30
EP2117565B1 (en) 2012-10-17
WO2008098871A3 (en) 2008-10-09
CO6210818A2 (es) 2010-10-20
AU2008214695B2 (en) 2013-10-03
CL2008000443A1 (es) 2008-08-22
WO2008098871A2 (en) 2008-08-21
AU2008214695A2 (en) 2009-09-03
IL200091A (en) 2013-05-30
PL2117565T3 (pl) 2013-03-29
EP2455086A1 (en) 2012-05-23
JP2016188252A (ja) 2016-11-04
HRP20120915T1 (hr) 2012-12-31
PT2117565E (pt) 2013-01-07
HK1132919A1 (en) 2010-03-12
DK2117565T3 (da) 2012-11-19
AR065317A1 (es) 2009-05-27
ME00828B (me) 2012-03-20
JP2014208709A (ja) 2014-11-06
EA019539B1 (ru) 2014-04-30
MA31237B1 (fr) 2010-03-01
CY1113822T1 (el) 2016-07-27
EP2117565A2 (en) 2009-11-18
CN101641103B (zh) 2013-05-15
CN101641103A (zh) 2010-02-03
ES2394169T3 (es) 2013-01-23
CA2676259A1 (en) 2008-08-21
SI2117565T1 (sl) 2013-01-31
UA101151C2 (ru) 2013-03-11
ZA200904975B (en) 2010-09-29

Similar Documents

Publication Publication Date Title
ECSP099631A (es) Composiciones de chitosanes para el tratamiento de enfermedades inflamatorias de las uñas
MX366773B (es) Composicion topica para lavado para su uso en pacientes con acne.
WO2012085523A3 (en) Skin sanitizer compositions comprising alcohol based emulsion
DOP2013000105A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis
AR081789A1 (es) Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel
ECSP13012546A (es) Formulación tópica para un inhibidor de jak
IN2014MN02288A (enExample)
BR112015005339A8 (pt) uso de óleo de semente de fruta milagrosa como um ingrediente ativo
WO2009016536A3 (en) Preservative compositions for moist wipes
HK1202448A1 (en) Topical formulation for administering a compound
MX2011012143A (es) Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas.
BR112015014367A2 (pt) formulações inibidoras de lfa-1
WO2014009862A3 (en) Cosmetic composition comprising benzylsulfonyl-d-ser-homophe-(4-amidino-benzylamide) and a polyalcohol
MX2012013607A (es) Polisacarido de las semillas de tamarindo para usarse en el tatamiento de enfermedades inflamatorias.
MY160377A (en) Topical pharmaceutical compositions
SG179131A1 (en) Modified erythropoietin to which water-soluble long-chain molecule is added
WO2013052380A3 (en) Compositions for enhancing nail health
GB2489173A (en) Multipurpose boat
EA201270148A1 (ru) Способ обработки волос
BR112014008172A2 (pt) composições para aumento da saúde da unha
IT1394921B1 (it) Uso di composti come principi attivi per migliorare l&#39;azione di riparazione cellulare dell&#39;epidermide umana, e composizioni farmaceutiche e cosmetiche che li contengono
WO2012095500A3 (en) Pharmaceutical compositions for the treatment of parasitic diseases, cancer, or skin diseases by topical administration
BR112017022026A2 (pt) composições para formulação cosmética de hidratação prolongada compreendendo manteiga de ucuuba com elevada concentração de ácido mirístico, bem como uso da dita formulação para preparação de um produto cosmético com alto poder hidrante e kit
AR082217A1 (es) Composiciones anti-inflamatorias
TH174373A (th) องค์ประกอบกันแดด